{
  "experiment_date": "2025-12-11 13:32:14",
  "experiment_type": "FDA Approval Prediction with Semi-Supervised Learning",
  "training_setup": {
    "n_labeled_total": 234,
    "n_labeled_train": 163,
    "n_test": 71,
    "n_unlabeled_available": 249453,
    "unlabeled_sizes_tested": [
      500,
      1000,
      2500,
      5000,
      10000
    ],
    "stratified_sampling": true,
    "train_test_split": "70-30"
  },
  "best_model_fda": {
    "method": "Co-Training",
    "n_unlabeled_used": 500,
    "f1_score": 0.8351648351648352,
    "accuracy": 0.7887323943661971,
    "precision": 0.7755102040816326,
    "recall": 0.9047619047619048,
    "roc_auc": 0.7873563218390804,
    "baseline_f1": 0.7764705882352941,
    "baseline_roc_auc": 0.8230706075533661,
    "improvement_percent": 7.559107559107561,
    "roc_improvement_percent": -4.3391521197007465,
    "training_time": 6.849046945571899
  },
  "methods_tested": [
    "Baseline (Supervised Random Forest)",
    "Label Propagation (Graph-based, hard labels)",
    "Label Spreading (Graph-based, soft labels)",
    "Self-Training (Iterative pseudo-labeling)",
    "Co-Training (Multi-view learning)"
  ],
  "key_findings": [
    "With only 163 labeled samples, semi-supervised learning improved F1-Score by +7.56%",
    "Best method: Co-Training using 500 unlabeled samples",
    "ROC-AUC changed from 0.8231 to 0.7874 (-4.34%)",
    "Demonstrates utility of unlabeled molecular data for FDA approval prediction"
  ]
}